<i>Bhlhe40</i>^<i>-/-</i> and <i>Bhlhe40</i>^<i>fl/fl</i><i>-Cd4-Cre</i> mice exhibit delayed bacterial clearance following <i>Chlamydia muridarum</i> intravagi... by Miguel A. B. Mercado (17847533)

Deletion of individual <i>sod</i> genes results in a compartment specific effect on sensitivity to oxidative stress in <i>clk-1</i> worms. by Claire E. Schaar (691681)

Electron hits on the exposed cell array with 10⁴ cells for 100 keV incident photons for administered doses of (a) 10 mGy, (b) 20 mGy, (c) 50 mGy, (d) 100 mGy and (e) 500... by Mehrdad Shahmohammadi Beni (796228)

Hemostatic abnormalities in COVID-19: A guided review by PLÍNIO C. SATHLER (10365401)

“…<div><p>Abstract The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 213 countries in a matter of weeks. …”

Anti-IL-10R blockade partially restores the ability of bacterial control in <i>Bhlhe40</i>-deficient mice. by Miguel A. B. Mercado (17847533)

The Efficacy of Taurolidine Lock Solution in Preventing Catheter-Related Bloodstream Infections in Pediatrics: A Systematic Review and Meta-Analysis by Congyu Qin (22386781)

A proposal program of management of severe oligozoospermia and azoospermia. by Jufeng Zheng (158910)

Trends in food consumption of schoolchildren from 2nd to 5th grade: a panel data analysis by Luciana Jeremias PEREIRA (10470669)

“…<div><p>ABSTRACT Objective To identify trends in food consumption among schoolchildren (2nd-5th grades) from public schools in the city of Florianópolis, Brazil, in a period of three years. …”

Selective C−H Activation of Haloalkanes using a Rhodiumtrispyrazolylborate Complex by Andrew J. Vetter (2349535)

“…By comparing the kinetic stabilities of a series of 1-chloroalkane activation products (C₁−C₅), it was found that the chlorine substituent dramatically decreases reductive elimination rates as the substitution is closer to the metal center. …”

Lipid droplets transiently increase in size during early stages of HSV-1 infection. by Kamal L. Nahas (13014698)

Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

“…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC₅₀ value in micromolar range. …”

Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

“…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC₅₀ value in micromolar range. …”

E1784K accelerates a component of slow inactivation with 1-10s time constants. by Colin H. Peters (4430245)

“…<p><b>(A1 and A2)</b> Sample inward sodium currents recorded after 20ms to 60s repolarization pulses to -90mV following either a 500ms or 64s depolarization to -30mV. …”

Venn diagram of co-expression of CrBV genes (A) and cluster heatmaps of gene expression levels in parasitized FAW (B). by Xian Li (201841)

Table_1_Decreased Vessel Density in Retinal Capillary Plexus and Thinner Ganglion Cell Complex Associated With Cognitive Impairment.DOCX by Kai Yang (73590)

Image_1_Decreased Vessel Density in Retinal Capillary Plexus and Thinner Ganglion Cell Complex Associated With Cognitive Impairment.TIF by Kai Yang (73590)

<i>In vitro</i> activity of aryl-thiazole derivatives against <i>Schistosoma mansoni</i> schistosomula and adult worms by Adriana S. A. Pereira (5900249)

“…After <i>in vitro</i> treatment for five days with 6.25 μM NJ05 or NJ07 separately, we observed a decrease of 30% in schistosomula viability, whilst treatment with NJ05+NJ07 lead to a reduction of 75% in viability measured by ATP quantitation and propidium iodide labeling. …”

Therapeutic administration of hMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia by Mary E. Irwin (293687)

“…This approach has improved clinical responses, but molecular remissions are seen in less than 50% of patients leaving few treatment options in the event of relapse. …”

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”